HPLC Determination of Pseudoephedrine Hydrochloride in Dog Plasma and the Preliminary Pharmacokinetic Study of Compound Pseudoephedrine Cetirizine Sustained Release Tablets

WANG Wei-peng,GU Zhuo-liang,NI Kun-yi,YU Shu-qin,ZHOU Guo-hua
DOI: https://doi.org/10.3321/j.issn:1001-2494.2005.07.018
2005-01-01
Abstract:OBJECTIVE To develop a specific and rapid HPLC method to determine Pseudoephedrine hydrochloride (PSE) in plasma and to investigate the pharmacokinetics of compound pseudoephedrine cetirizine sustained release tablets in dogs. METHODS The plasma samples were extracted by ether. Phenylalanine hydrochloride(Phen) was used as the internal standard. Lichrospher C18 column was used with a mobile phase of methanol-water( 11 :29) .RESULTS PSE, Phen and the impurities in plasma were separated efficiently. A good linearity over the range of 0.10 to 10.00 μmol · L-1 was achieved. The recovery, accuracy and precision of intra-day and inter-day were all qualified.The concentrations of PSE in dog plasma were measured at different time points after oral administration of compound pseudoephedrine cetirizine sustained release tablets (T) and regular tablets(C) .The main pharmacokinetic parameters were obtained as follows: t1/2(1) (4.66 ± 1.43)h, t1/2(c) (3.78 ± 1.91)h, tmax(T)(4.0± 1.4)h, t max(C)(2.3 ± 0.5)h, C max(T) (5.47 ±2.41)μmol·L-1, cmax(c)( 12.31 ±3.57)μmol·-1.CONCLUSION The sustained release PSE tablet released more slowly.Its t1/2 was extended, and its maximal concentration was decreased significantly.
What problem does this paper attempt to address?